ADC Therapeutics SA SEC filings ADCT
ADC Therapeutics SA has 438 filings in SEC EDGAR's recent list, going back to Jun 27, 2019. Its latest annual report, Form ARS, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| S-4 | Registration for a merger or exchange | Nov 3, 2026 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Oct 13, 2026 | Oct 7, 2026 |
| S-8 | Employee stock plan registration | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 3, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2026 | Jun 1, 2026 |
| 10-Q | Quarterly report | May 4, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| DEFA14A | Additional proxy material | Apr 20, 2026 | — |
| DEF 14A | Proxy statement | Apr 20, 2026 | Jun 1, 2026 |
| 424B3 | Prospectus | Apr 15, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Jun 1, 2026 |
| EFFECT | Filing | Mar 16, 2026 | — |
| 424B3 | Prospectus | Mar 16, 2026 | — |
| CORRESP | Letter to the SEC | Mar 12, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2026 | — |
| S-3 | Shelf registration | Mar 10, 2026 | — |
| ARS | Annual report to shareholders | Mar 10, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 23, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| EFFECT | Filing | Dec 12, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| CORRESP | Letter to the SEC | Dec 10, 2025 | — |
| S-3/A | Form s-3/a | Dec 9, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 5, 2025 | Dec 3, 2025 |
| S-3 | Shelf registration | Nov 10, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Oct 14, 2025 | Oct 12, 2025 |
| S-8 | Employee stock plan registration | Sep 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 424B3 | Prospectus | Jul 10, 2025 | — |
| EFFECT | Filing | Jul 9, 2025 | — |
| CORRESP | Letter to the SEC | Jul 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2025 | — |
| S-3 | Shelf registration | Jun 30, 2025 | — |
| 8-K |
Current report
Material agreement, Exit or restructuring costs, Unregistered share sale
|
Jun 12, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 3, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| DEF 14A | Proxy statement | Apr 21, 2025 | Jun 3, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 9, 2025 | Jun 3, 2025 |
| ARS | Annual report to shareholders | Mar 27, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 13, 2024 | Nov 11, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| DEFA14A | Additional proxy material | Sep 23, 2024 | — |
| DEF 14A | Proxy statement | Sep 23, 2024 | Nov 11, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 13, 2024 | Nov 11, 2024 |
| EFFECT | Filing | Aug 13, 2024 | — |
| CORRESP | Letter to the SEC | Aug 9, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2024 | — |
| S-3 | Shelf registration | Aug 6, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Other events
|
May 8, 2024 | May 6, 2024 |
| 424B5 | Prospectus supplement | May 7, 2024 | — |
| 424B5 | Prospectus supplement | May 6, 2024 | — |
| 10-Q | Quarterly report | May 6, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2024 | May 6, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 13, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 9, 2024 | Apr 9, 2024 |
| 424B3 | Prospectus | Mar 15, 2024 | — |
| 424B3 | Prospectus | Mar 15, 2024 | — |
| EFFECT | Filing | Mar 14, 2024 | — |
| EFFECT | Filing | Mar 14, 2024 | — |
| EFFECT | Filing | Mar 14, 2024 | — |
| POS AM | Form pos am | Mar 13, 2024 | — |
| POS AM | Form pos am | Mar 13, 2024 | — |
| POS AM | Form pos am | Mar 13, 2024 | — |
| ARS | Annual report to shareholders | Mar 13, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2024 | Mar 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 29, 2024 | Feb 23, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 24, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 19, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 6-K | Current report (foreign issuer) | Dec 19, 2023 | Dec 19, 2023 |
| S-8 | Employee stock plan registration | Dec 18, 2023 | — |
| S-8 | Employee stock plan registration | Dec 4, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 7, 2023 | Nov 7, 2023 |
| 6-K | Current report (foreign issuer) | Nov 7, 2023 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Sep 11, 2023 | Sep 11, 2023 |
| 6-K | Current report (foreign issuer) | Aug 31, 2023 | Aug 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 8, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jul 20, 2023 | Jul 20, 2023 |
| 6-K | Current report (foreign issuer) | Jul 11, 2023 | Jul 11, 2023 |
| 6-K | Current report (foreign issuer) | Jun 14, 2023 | Jun 14, 2023 |
| 6-K | Current report (foreign issuer) | May 9, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | May 5, 2023 | May 5, 2023 |
| SC TO-I/A | Form sc to-i/a | Apr 5, 2023 | — |
| SC TO-I/A | Form sc to-i/a | Mar 30, 2023 | — |
| SC TO-I/A | Form sc to-i/a | Mar 29, 2023 | — |
| EFFECT | Filing | Mar 24, 2023 | — |
| CORRESP | Letter to the SEC | Mar 21, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2023 | — |
| EFFECT | Filing | Mar 20, 2023 | — |
| SC TO-I/A | Form sc 10-1/a | Mar 17, 2023 | — |
| CORRESP | Letter to the SEC | Mar 16, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 15, 2023 | — |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 15, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | Mar 15, 2023 | Dec 31, 2022 |
| UPLOAD | Letter from the SEC | Mar 14, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 13, 2023 | Mar 13, 2023 |
| SC TO-I | Form sc to-i | Mar 6, 2023 | — |
| SC TO-C | Form sc to-c | Mar 3, 2023 | — |
| 6-K | Current report (foreign issuer) | Feb 28, 2023 | Feb 28, 2023 |
| 6-K | Current report (foreign issuer) | Feb 6, 2023 | Feb 6, 2023 |
| 424B7 | Form 424b7 | Feb 2, 2023 | — |
| FWP | Free writing prospectus | Feb 2, 2023 | — |
| 6-K | Current report (foreign issuer) | Feb 2, 2023 | Feb 2, 2023 |
| FWP | Free writing prospectus | Feb 2, 2023 | — |
| 6-K | Current report (foreign issuer) | Jan 9, 2023 | Jan 9, 2023 |
| 6-K | Current report (foreign issuer) | Jan 4, 2023 | Jan 4, 2023 |
| 6-K | Current report (foreign issuer) | Jan 4, 2023 | Jan 4, 2023 |
| 6-K | Current report (foreign issuer) | Dec 21, 2022 | Dec 21, 2022 |
| 6-K | Current report (foreign issuer) | Dec 19, 2022 | Dec 19, 2022 |
| 6-K | Current report (foreign issuer) | Nov 8, 2022 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 7, 2022 | Nov 7, 2022 |
| 6-K | Current report (foreign issuer) | Nov 3, 2022 | Nov 3, 2022 |
| 6-K | Current report (foreign issuer) | Nov 2, 2022 | Nov 2, 2022 |
| 6-K | Current report (foreign issuer) | Nov 1, 2022 | Nov 1, 2022 |
| 6-K | Current report (foreign issuer) | Oct 31, 2022 | Oct 31, 2022 |
| 6-K | Current report (foreign issuer) | Sep 22, 2022 | Sep 21, 2022 |
| EFFECT | Filing | Sep 16, 2022 | — |
| EFFECT | Filing | Sep 16, 2022 | — |
| 424B3 | Prospectus | Sep 16, 2022 | — |
| 424B3 | Prospectus | Sep 16, 2022 | — |
| 6-K | Current report (foreign issuer) | Sep 16, 2022 | Sep 16, 2022 |
| CORRESP | Letter to the SEC | Sep 14, 2022 | — |
| CORRESP | Letter to the SEC | Sep 14, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2022 | — |
| 6-K | Current report (foreign issuer) | Sep 7, 2022 | Sep 7, 2022 |
| F-3 | Shelf registration (foreign issuer) | Sep 6, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 6, 2022 | — |
| POS AM | Form pos am | Aug 16, 2022 | — |
| 6-K | Current report (foreign issuer) | Aug 15, 2022 | Aug 15, 2022 |
| 6-K | Current report (foreign issuer) | Aug 9, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Aug 2, 2022 | Aug 2, 2022 |
| 6-K | Current report (foreign issuer) | Jul 27, 2022 | Jul 27, 2022 |
| 6-K | Current report (foreign issuer) | Jul 20, 2022 | Jul 20, 2022 |
| 6-K | Current report (foreign issuer) | Jul 11, 2022 | Jul 11, 2022 |
| 6-K | Current report (foreign issuer) | Jul 11, 2022 | Jul 11, 2022 |
| 6-K | Current report (foreign issuer) | Jun 30, 2022 | Jun 30, 2022 |
| S-8 | Employee stock plan registration | Jun 30, 2022 | — |
| 6-K | Current report (foreign issuer) | Jun 29, 2022 | Jun 29, 2022 |
| 6-K | Current report (foreign issuer) | Jun 13, 2022 | Jun 13, 2022 |
| 6-K | Current report (foreign issuer) | Jun 10, 2022 | Jun 10, 2022 |
| 6-K | Current report (foreign issuer) | Jun 1, 2022 | Jun 1, 2022 |
| 6-K | Current report (foreign issuer) | May 20, 2022 | May 20, 2022 |
| 6-K | Current report (foreign issuer) | May 12, 2022 | May 12, 2022 |
| 6-K | Current report (foreign issuer) | May 9, 2022 | Mar 31, 2022 |
| 6-K | Current report (foreign issuer) | May 9, 2022 | May 9, 2022 |
| 6-K | Current report (foreign issuer) | May 4, 2022 | May 4, 2022 |
| 6-K | Current report (foreign issuer) | May 3, 2022 | May 3, 2022 |
| 6-K | Current report (foreign issuer) | Apr 4, 2022 | Apr 4, 2022 |
| 6-K | Current report (foreign issuer) | Mar 17, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Mar 17, 2022 | Mar 17, 2022 |
| 20-F | Annual report (foreign issuer) | Mar 17, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Mar 3, 2022 | Mar 3, 2022 |
| 6-K | Current report (foreign issuer) | Mar 3, 2022 | Mar 3, 2022 |
| 6-K | Current report (foreign issuer) | Mar 1, 2022 | Mar 1, 2022 |
| 6-K | Current report (foreign issuer) | Feb 24, 2022 | Feb 24, 2022 |
| 6-K | Current report (foreign issuer) | Feb 17, 2022 | Feb 17, 2022 |
| 6-K | Current report (foreign issuer) | Feb 8, 2022 | Feb 8, 2022 |
| 6-K | Current report (foreign issuer) | Feb 2, 2022 | Feb 2, 2022 |
| 6-K | Current report (foreign issuer) | Jan 20, 2022 | Jan 20, 2022 |
| 6-K | Current report (foreign issuer) | Jan 18, 2022 | Jan 18, 2021 |
| 6-K | Current report (foreign issuer) | Nov 9, 2021 | Nov 9, 2021 |
| 6-K | Current report (foreign issuer) | Nov 4, 2021 | Nov 4, 2021 |
| 6-K | Current report (foreign issuer) | Nov 2, 2021 | Sep 30, 2021 |
| 6-K | Current report (foreign issuer) | Oct 29, 2021 | Oct 29, 2021 |
| 6-K | Current report (foreign issuer) | Oct 27, 2021 | Oct 27, 2021 |
| 6-K | Current report (foreign issuer) | Sep 29, 2021 | Sep 29, 2021 |
| 6-K | Current report (foreign issuer) | Sep 27, 2021 | Sep 27, 2021 |
| 6-K | Current report (foreign issuer) | Sep 23, 2021 | Sep 23, 2021 |
| 6-K | Current report (foreign issuer) | Sep 13, 2021 | Sep 13, 2021 |
| 6-K | Current report (foreign issuer) | Sep 9, 2021 | Sep 9, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ADCT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Epalinges, Switzerland
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1771910
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.